Cargando…
Growth differentiation factor‐15 as a prognostic biomarker in cancer patients
Autores principales: | Ishida, Junichi, Konishi, Masaaki, Saitoh, Masakazu, Springer, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876072/ https://www.ncbi.nlm.nih.gov/pubmed/27493877 http://dx.doi.org/10.1002/jcsm.12123 |
Ejemplares similares
-
The concept that focuses on oral motor and feeding function in cancer patients with muscle wasting: Skeletal muscle mass is associated with severe dysphagia in cancer patients
por: Saitoh, Masakazu, et al.
Publicado: (2016) -
Clinical perspective for wasting in diaphragm, an ever‐trained muscle
por: Konishi, Masaaki, et al.
Publicado: (2016) -
Concern regarding quality and quality of muscle
por: Saitoh, Masakazu, et al.
Publicado: (2015) -
Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
por: Ishida, Junichi, et al.
Publicado: (2015) -
Irisin – a myokine potentially bridging muscle and fat tissue in cachexia
por: Konishi, Masaaki, et al.
Publicado: (2015)